SAN DIEGO--(BUSINESS WIRE)--May 1, 2019--
Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical
company focused on discovering, acquiring, developing and
commercializing therapeutics in the disease areas of immunology,
inflammation and oncology, today announced that Sheila Gujrathi, M.D.,
Chief Executive Officer and Co-Founder, will participate in a fireside
chat at the Bank of America Merrill Lynch Health Care Conference onTuesday, May 14 at 1:00 p.m. PT.
A live webcast of the fireside chat will be available on the “Events and
Presentations” page in the “Investors” section of the company’s website
A replay of the webcast will be archived on the company’s website for 90
days following the presentation.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on
discovering, acquiring, developing and commercializing therapeutics in
the disease areas of immunology, inflammation and oncology. Its goal is
to be an industry leader in each of these therapeutic areas and to
enhance and extend the lives of patients suffering from such diseases.
More information can be found at www.gossamerbio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190501005255/en/
Source: Gossamer Bio, Inc.